A New Nonlinear Mixture Response Surface Paradigm for the Study of Synergism: A Three Drug Example

Publisher： Bentham Science Publishers

E-ISSN： 1875-5453|4|5|399-409

ISSN： 1389-2002

Source： Current Drug Metabolism, Vol.4, Iss.5, 2003-10, pp. : 399-409

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Asthma pharmacogenetic study using finite mixture models to handle drug-response heterogeneity

By York Timothy P   Vargas-Irwin Cristina   Anderson Wayne H   van den Oord Edwin JCG  

Pharmacogenomics, Vol. 10, Iss. 5, 2009-05 ,pp. : 753-767

Future Medicine

Access to resources Recommend Favorite

“Smart” Nanocarriers: A New Paradigm for Tumor Targeting Drug Delivery Systems

By Hu Zhigang   Huo Fei   Zhang Yi   Chen Chunyang   Tu Kehua   Jiang Hongliang   Wang Li-Qun  

Drug Delivery Letters, Vol. 1, Iss. 1, 2011-09 ,pp. : 67-84

Bentham Science Publishers

Access to resources Recommend Favorite

Drug Targeting Based on a New Concept-Targeting Against TLR4 as an Example

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 15, Iss. 2, 2015-06 ,pp. : 83-87

Bentham Science Publishers

Access to resources Recommend Favorite

A Mixture Dose–Response Model for Identifying High‐Dimensional Drug Interaction Effects on Myopathy Using Electronic Medical Record Databases

By  

Cpt: Pharmacometrics & Systems Pharmacology, Vol. 4, Iss. 8, 2015-08 ,pp. : 474-480

John Wiley & Sons Inc

Access to resources Recommend Favorite

Ligand-based receptor tyrosine kinase partial agonists: new paradigm for cancer drug discovery?

By Riese David J  

Expert Opinion on Drug Discovery, Vol. 6, Iss. 2, 2011-02 ,pp. : 185-193

Informa Healthcare

Access to resources Recommend Favorite